Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tesevatinib |
Trade Name | |
Synonyms | KD019|XL647|EXEL 7647|KD 019 |
Drug Descriptions |
Tesevatinib (XL647) is an inhibitor of multiple receptor tyrosine kinases, including ERBB2 (HER2), EGFR, VEGFR2 and VEGFR3, and EphB4, potentially resulting in decreased tumor growth and angiogenesis (PMID: 17575237, PMID: 30030583). |
DrugClasses | EGFR Inhibitor (Pan) 62 EPHB4 Inhibitor 6 HER2 Inhibitor 42 VEGFR2 Inhibitor 37 VEGFR3 Inhibitor 6 |
CAS Registry Number | 781613-23-8 |
NCIT ID | C62496 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Tesevatinib | Tesevatinib | 0 | 2 |
Tesevatinib + Trastuzumab | Tesevatinib Trastuzumab | 0 | 1 |